Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-106467
Filing Date
2021-04-05
Accepted
2021-04-05 17:06:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d910944ddefa14a.htm DEFA14A 20197
2 GRAPHIC g41684g01v01.jpg GRAPHIC 246398
3 GRAPHIC g41684g02v02.jpg GRAPHIC 175412
  Complete submission text file 0001193125-21-106467.txt   602595
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34375 | Film No.: 21806414
SIC: 3841 Surgical & Medical Instruments & Apparatus